CA Cancer J Clin. 1991 May-Jun;41(3):187-92. doi: 10.3322/canjclin.41.3.187.
"Laetrile" is used interchangeably with "amygdalin" to designate natural substances, derived primarily from apricots and almonds, that can release cyanide, which is lethal to living organisms. In the 1920s, Dr. Ernst T. Krebs, Sr., formulated a theory that amygdalin could kill cancer cells. His theory was inconsistent with biochemical facts and has since been modified at least twice by his son, Ernst T. Krebs, Jr. Extensive work has been done by cancer scientists to test the claim that Laetrile fights cancer. Many animal experiments in the 1970s showed a complete lack of tumor killing by Laetrile. Reviews of the medical records of patients whose cancers were claimed to be reduced or cured after Laetrile treatment found insufficient medical evidence to judge Laetrile's efficacy. Finally, in a clinical trial in cancer patients reported in 1982, Laetrile neither caused shrinkage of tumors, nor increased survival time, nor alleviated cancer symptoms, nor enhanced well-being. Several reports in the medical literature document instances in which Laetrile has caused serious, life-threatening toxicity when taken in large doses in the manner prescribed by Laetrile advocates. In light of the lack of efficacy of Laetrile and its demonstrated ability to cause harm, Laetrile should not be used to treat cancer.
“苦杏仁苷”与“扁桃苷”可互换使用,指主要从杏子和杏仁中提取的天然物质,这些物质可释放对生物体致命的氰化物。20世纪20年代,老恩斯特·T·克雷布斯博士提出一种理论,认为扁桃苷可以杀死癌细胞。他的理论与生化事实不符,此后至少被他的儿子小恩斯特·T·克雷布斯修改过两次。癌症科学家们进行了大量研究,以验证苦杏仁苷抗癌的说法。20世纪70年代的许多动物实验表明,苦杏仁苷完全没有杀死肿瘤的作用。对那些声称在接受苦杏仁苷治疗后癌症病情减轻或治愈的患者病历进行的审查发现,没有足够的医学证据来判断苦杏仁苷的疗效。最后,在1982年报道的一项针对癌症患者的临床试验中,苦杏仁苷既没有使肿瘤缩小,也没有延长生存时间,没有缓解癌症症状,也没有改善健康状况。医学文献中的几份报告记录了这样的案例:按照苦杏仁苷倡导者规定的方式大剂量服用苦杏仁苷时,会导致严重的、危及生命的毒性。鉴于苦杏仁苷缺乏疗效且已证明具有危害性,不应将其用于治疗癌症。